PATENT CLAIM ANALYSIS

Application Number: 15997040
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "364100"]

Abstract:
The present disclosure relates to solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament.

Claim (Index 14):
The crystalline form I\u2032 of N\u2014((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((S)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide (Ia) according to  claim 3 , further having an X-ray powder diffraction pattern comprising characteristic peaks at about 11.4, 14.9, 17.7, 20.5, and 27.2 degrees 2-theta.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.55814
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15547193', '15997028', '15564878', '14110596', '12561398']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7235834006581889
- 35 USC 102 Novelty (BERT): 0.6107445433197038
- Combined Prediction Score: 0.7122995149243404
- Mean Citation Score: 405.072322
- Max Citation Score: 537.6759999999998
- Similarity Product: 499.7292605314253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test